Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Chizhik opened a distribution center in the Moscow region

8/29/24 X5

VK has moved all video content to a single Opecloud repository

8/29/24 VKCO

Etalon reported for 6 months of 2024

8/29/24 ETLN

Mostotrest reported for 6 months of 2024 by IFRS

8/29/24 MSTT

En+ Group reported for 6 months of 2024 by IFRS

8/29/24 ENPG

AMZ reported for 6 months of 2024 by IFRS

8/29/24 AMEZ

Board of Directors of MD Medical Group Investments recommended dividends

8/29/24 MDMG

Saratov Oil Refinery reported for 6 months of 2024 by IFRS

8/29/24 KRKN

Permenergosbyt reported for 6 months of 2024 by IFRS

8/29/24 PMSB

Promomed reported for 6 months of 2024 by IFRS

8/29/24 PRMD